Nice post Js!
Good, important point re debt free. Another factor to support a high sp once things fall into place.
Alternatively if circumstances become appropriate Corr could arrange good financing if necessary to help until sales cover us rather than a cr down the track; maybe.
On the subject of cr's I doubt we common shareholders will be involved in the next either. However if the sp is overpriced following the release of ct results, which I also doubt will occur, they might consider it wise to do a consolidation and large cr.
Your point about a licensee charging more than $300 is very interesting. Given that research indicates sufferers are willing to pay up to $1400 p.a. on products for resolution, it may be determined profits will be greater from sacrificing retail volume for a higher retail price - 600, 900, 1200. (they can't charge patients more than retail of course)
Are you becoming more confident in the value of pericoach and ALT's future?
- Forums
- ASX - By Stock
- ALT
- ALT in enviable position!
ALT in enviable position!, page-6
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online